Roger is Professor of Clinical Neuroscience at the University of Cambridge and Consultant Neurologist at Addenbrooke’s Hospital. He also leads the regional NHS Huntington’s Disease as well as an NHS Parkinson’s Disease clinic. His research explores the heterogeneity of these disorders and its basis which has informed work he has conducted on trialling new experimental therapeutics for these conditions including cell and gene therapies as well as drug repurposing.
Notably, he serves as the lead academic scientist of the Alzheimer’s Research UK funded Drug Discovery Institute in Cambridge as well as the John Van Geest Centre for Brain Repair. He is also a Co-editor in chief of the Journal of Neurology as well as an integral part of the World Parkinson Coalition, which highlights his commitment to working with patients and clinicians in advancing our understanding and treatment of neurodegenerative diseases.
